TC-E 5006γ-secretase modulator; reduces Aβ42 levels CAS# 1257395-14-4 |
2D Structure
- Nadifloxacin
Catalog No.:BCC4804
CAS No.:124858-35-1
- Calcipotriol monohydrate
Catalog No.:BCC1445
CAS No.:147657-22-5
- Halobetasol Propionate
Catalog No.:BCC4664
CAS No.:66852-54-8
- Dihydroartemisinin
Catalog No.:BCN6264
CAS No.:71939-50-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1257395-14-4 | SDF | Download SDF |
PubChem ID | 68414868 | Appearance | Powder |
Formula | C29H29F4NO2 | M.Wt | 499.54 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO and to 100 mM in ethanol | ||
Chemical Name | 2-[4-[(4-fluorophenyl)-(4-methylpiperidin-1-yl)methyl]-3-[4-(trifluoromethyl)phenyl]phenyl]propanoic acid | ||
SMILES | CC1CCN(CC1)C(C2=CC=C(C=C2)F)C3=C(C=C(C=C3)C(C)C(=O)O)C4=CC=C(C=C4)C(F)(F)F | ||
Standard InChIKey | ONYWALXTZFPKAS-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C29H29F4NO2/c1-18-13-15-34(16-14-18)27(21-5-10-24(30)11-6-21)25-12-7-22(19(2)28(35)36)17-26(25)20-3-8-23(9-4-20)29(31,32)33/h3-12,17-19,27H,13-16H2,1-2H3,(H,35,36) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | γ-secretase modulator. Reduces Aβ42 levels in vitro (EC50 = 390 nM) and in vivo. Orally bioavailable. |
TC-E 5006 Dilution Calculator
TC-E 5006 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0018 mL | 10.0092 mL | 20.0184 mL | 40.0368 mL | 50.046 mL |
5 mM | 0.4004 mL | 2.0018 mL | 4.0037 mL | 8.0074 mL | 10.0092 mL |
10 mM | 0.2002 mL | 1.0009 mL | 2.0018 mL | 4.0037 mL | 5.0046 mL |
50 mM | 0.04 mL | 0.2002 mL | 0.4004 mL | 0.8007 mL | 1.0009 mL |
100 mM | 0.02 mL | 0.1001 mL | 0.2002 mL | 0.4004 mL | 0.5005 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- GSK 789472 hydrochloride
Catalog No.:BCC7818
CAS No.:1257326-24-1
- NPEC-caged-dopamine
Catalog No.:BCC7837
CAS No.:1257326-23-0
- NPEC-caged-serotonin
Catalog No.:BCC7836
CAS No.:1257326-22-9
- NPEC-caged-(S)-3,4-DCPG
Catalog No.:BCC7652
CAS No.:1257323-85-5
- NPEC-caged-(S)-AMPA
Catalog No.:BCC7789
CAS No.:1257323-84-4
- NPEC-caged-noradrenalin
Catalog No.:BCC7835
CAS No.:1257323-83-3
- TC-G 24
Catalog No.:BCC6146
CAS No.:1257256-44-2
- TC-SP 14
Catalog No.:BCC7926
CAS No.:1257093-40-5
- ABT-199
Catalog No.:BCC3614
CAS No.:1257044-40-8
- TPTU
Catalog No.:BCC2827
CAS No.:125700-71-2
- TDBTU
Catalog No.:BCC2825
CAS No.:125700-69-8
- TBTU
Catalog No.:BCC2823
CAS No.:125700-67-6
- TBA354
Catalog No.:BCC6459
CAS No.:1257426-19-9
- Amikacin hydrate
Catalog No.:BCC4621
CAS No.:1257517-67-1
- CEP-33779
Catalog No.:BCC2199
CAS No.:1257704-57-6
- Pristimerin
Catalog No.:BCN2315
CAS No.:1258-84-0
- Parathyroid Hormone (1-34), bovine
Catalog No.:BCC1040
CAS No.:12583-68-5
- Deacetylorientalide
Catalog No.:BCN7310
CAS No.:1258517-59-7
- 9-O-Ethyldeacetylorientalide
Catalog No.:BCN7311
CAS No.:1258517-60-0
- LY2940680
Catalog No.:BCC3935
CAS No.:1258861-20-9
- (+)-Glaucarubinone
Catalog No.:BCN7956
CAS No.:1259-86-5
- 24-Methylenecycloartanol acetate
Catalog No.:BCN6137
CAS No.:1259-94-5
- SAMS Peptide
Catalog No.:BCC5745
CAS No.:125911-68-4
- JP 1302 dihydrochloride
Catalog No.:BCC7449
CAS No.:1259314-65-2
Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable gamma-Secretase Modulator.[Pubmed:24900267]
ACS Med Chem Lett. 2011 Aug 5;2(10):786-91.
We have investigated a novel series of acid-derived gamma-secretase modulators as a potential treatment of Alzheimer's disease. Optimization based on cellular potency and brain pharmacodynamics after oral dosing led to the discovery of 10a (BIIB042). Compound 10a is a potent gamma-secretase modulator, which lowered Abeta42, increased Abeta38, but had little to no effect on Abeta40 levels both in vitro and in vivo. In addition, compound 10a did not affect Notch signaling in our in vitro assessment. Compound 10a demonstrated excellent pharmacokinetic parameters in multiple species. Oral administration of 10a significantly reduced brain Abeta42 levels in CF-1 mice and Fischer rats, as well as plasma Abeta42 levels in cynomolgus monkeys. Compound 10a was selected as a candidate for preclinical safety evaluation.